Farms.com Home   Ag Industry News

American Meat Institute calls newest COOL rule ‘reckless’

American Meat Institute calls newest COOL rule ‘reckless’

By Amanda Brodhagen, Farms.com

The American Meat Institute (AM) is speaking out strongly against the U.S. Department of Agriculture’s final rule on its controversial country-of-origin labeling (COOL) rule. The institute says that no changes were made to the proposal despite industry opposition over additional costs that would be insured by companies and hurting trade ties with Canada and Mexico.

The Senior Vice President of AMI Mark Dopp, said that the new rule could harm American agriculture, noting that during the consultation progress, U.S. meat companies and livestock producers expressed their concerns over the proposal. “The decision to proceed with a rule that is more costly, complex and burdensome than the earlier version,  when WTO and our trading partners have sent strong signals that this is no ‘fix,’ shows a reckless disregard for trade relations and for companies whose very survival is at risk because they rely upon imported livestock,” said Dopp.

Perhaps the most worrisome comment that Dopp mentioned is how the rule will likely prompt several meat companies to shut down due to the additional costs. The ramped up COOL regulations would not only impact the domestic meat industry says Dopp, but operations north and south of the boarders would be even more worse off. The institute says this move signals that the government is picking winners and losers.
 


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.